XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings per Share (Tables)
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of the basic and diluted earnings per share attributable to the Company's common shareholders for the three months ended March 31, 2022 and 2021:
Three Months Ended
March 31,
(in thousands, except per share amounts)20222021
EPS numerator:  
Net loss$(1,516)$(2,282)
EPS denominator:
Weighted average shares outstanding – basic
10,421 9,218 
Impact of dilutive securities(1)
— — 
Weighted average shares outstanding – diluted
10,421 9,218 
EPS:
Basic
$(0.15)$(0.25)
Diluted$(0.15)$(0.25)
(1)    For the three months ended March 31, 2022 and 2021, the Company excluded 153,741 and 603,847, respectively, of weighted average anti-dilutive securities related to certain of the Company's outstanding common stock warrants, shares issued in conjunction with the Company's ESPP and nonvested RSUs.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The following table summarizes the securities that were antidilutive or out-of-the-money, and therefore, were not included in the computations of diluted income per common share:
 Three Months Ended
March 31,
 20222021
In-the-money warrants— 365,556 
Out-of-the-money warrants (see Note 7)
1,229,643 600,000 
Service-based RSUs (See Note 14)
70,999 143,647 
Performance and market-based RSUs(1)
87,053 90,729 
Employee Stock Purchase Plan3,547 3,627 
Total1,391,242 1,203,559 
(1)    For the three months ended March 31, 2022 and 2021, certain PRSU and MRSU awards (each defined in Note 14) were not included in the computation of diluted income per common share because the performance and market conditions were not satisfied during the periods and would not be satisfied if the reporting date was at the end of the contingency period.